Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jul;89(1):18-21.
doi: 10.1111/j.1365-2249.1992.tb06870.x.

Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?

P E Ruuska  1 , I Ikäheimo, S Silvennoinen-Kassinen, M L Käär, A Tiilikainen
Affiliations

Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?

P E Ruuska et al. Clin Exp Immunol. 1992 Jul.

Abstract

Expression of the erythrocyte complement receptor (C3bR = CR1 = CD35) and its genomic polymorphism (HindIII RFLP) was studied in a group of 80 patients with IDDM, 31 healthy siblings and 101 healthy blood donors. Defective CR1 expression was found in 26% of the patients with IDDM compared with 9% of the controls (P less than 0.05) and 0% of the siblings. The CR1 gene polymorphism of the IDDM patients did not significantly differ from that of the controls. The presence of a 6.9 kb (L) CR1 gene fragment was associated with a low CR1 expression in the patients (P less than 0.05) and especially in the controls (P less than 0.001). No significant association was found between the presence or absence of the HLA risk antigens for IDDM and CR1 expression. The results confirm that erythrocyte CR1 expression is genetically determined, but the CR1 deficiency associated with IDDM seems to be an acquired rather than a genetic phenomenon.

PubMed Disclaimer

References

    1. Clin Exp Immunol. 1982 Jun;48(3):715-25 - PubMed
    1. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1245-9 - PubMed
    1. Clin Immunol Immunopathol. 1989 Dec;53(3):358-99 - PubMed
    1. Clin Exp Immunol. 1986 Jan;63(1):41-8 - PubMed
    1. J Clin Invest. 1986 Oct;78(4):977-82 - PubMed

Publication types

Substances